ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,967.23
      -0.88%
      US Tech 100
      16,580.40
      -2.10%
      Dow Jones
      37,986.40
      0.56%
      Brent Oil
      86.625
      0.24%
      Bitcoin
      63,945.74
      0.69%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ionis Pharmaceuticals Inc (IONS)

      7. Ionis Pharmaceuticals Inc (IONS) News

      IONS Ionis Pharmaceuticals Inc

      40.68
      -0.13 (-0.32%)
      After Hours
      Last Updated: 16:15:01
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Ionis Pharmaceuticals Inc IONS NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.13 -0.32% 40.68 16:15:01
      Open Price Low Price High Price Close Price Prev Close
      40.88 40.385 41.155 40.68 40.81
      more quote information »

      Recent News

      Date Time Source Heading
      4/07/202409:48PRNUSIonis presents positive results from Phase 3 Balance study..
      4/01/202407:05PRNUSIonis to present at upcoming investor conferences
      3/28/202407:05PRNUSIonis to hold olezarsen Phase 3 data webcast
      3/25/202408:18PRNUSPositive olezarsen Phase 3 data in familial chylomicronemia..
      3/13/202407:00PRNUSIonis announces positive results from Phase 2 study of..
      3/06/202407:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
      3/04/202419:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/04/202419:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/04/202419:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/04/202419:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/04/202419:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202409:10EDGAR2Form 8-K - Current report
      2/29/202409:05PRNUSIonis announces new chief global product strategy officer to..
      2/28/202407:05PRNUSIonis to present at upcoming investor conferences
      2/21/202411:17EDGAR2Form 8-K - Current report
      2/21/202407:00PRNUSIonis reports fourth quarter and full year 2023 financial..
      2/20/202410:39EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
      2/16/202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/16/202416:34EDGAR2Form 144 - Report of proposed sale of securities
      2/15/202407:00PRNUSOlezarsen receives Orphan Drug designation from U.S. FDA for..
      2/14/202410:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      2/13/202406:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/08/202407:00PRNUSEplontersen granted U.S. FDA Fast Track designation for..
      2/07/202407:05PRNUSIonis to hold fourth quarter and full year 2023 financial..
      2/02/202419:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202419:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202419:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202419:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202419:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202417:34EDGAR2Form 144 - Report of proposed sale of securities
      2/02/202417:31EDGAR2Form 144 - Report of proposed sale of securities
      2/02/202417:30EDGAR2Form 144 - Report of proposed sale of securities
      2/02/202417:28EDGAR2Form 144 - Report of proposed sale of securities
      2/02/202417:25EDGAR2Form 144 - Report of proposed sale of securities
      2/02/202417:23EDGAR2Form 144 - Report of proposed sale of securities
      2/02/202417:21EDGAR2Form 144 - Report of proposed sale of securities
      2/02/202417:19EDGAR2Form 144 - Report of proposed sale of securities
      1/31/202421:30EDGAR2Form 144 - Report of proposed sale of securities
      1/29/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/29/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/26/202414:37EDGAR2Form 144 - Report of proposed sale of securities
      1/26/202414:09EDGAR2Form 144 - Report of proposed sale of securities
      1/22/202407:10EDGAR2Form 8-K - Current report
      1/22/202407:00PRNUSIonis announces positive topline results from Phase 3..
      1/18/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/18/202417:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/18/202417:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      IONS
      Ionis Pharmaceuticals
      Delayed Upgrade Clock